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Janka Petravic1, Thomas H Vanderford2, Guido Silvestri2 and Miles Davenport1*Abstract
Background: There is significant debate about whether the gut plays a major role in viral replication and
pathology in HIV infection. Here we aimed to estimate the contribution of the gut to the total virus observed in
plasma, by comparing the frequency of different viral mutants in plasma and gut in SIV infection.
Results: We found that the maximum contribution of gut to plasma viral load estimated from rectal biopsy at day
28 post-infection had a median of 10%. The estimated values for individual animals ranged from nearly 100%
to <3% in 4/14 animals. Importantly, these are maximum estimates, so that a value of 90%, for example, means
that the real contribution may be anything between 0 and 90%, just not higher than 90%.
We also studied the contribution of gut at the peak of plasma viral load (day 14). However, since there was very
little escape in most animals at this time point, we could only estimate the maximal contribution of gut in 4
animals, in two of which it was <15%.
Conclusions: The role of the gut in HIV is a controversial area, with many suggesting that it plays a dominant role
in driving early infection. Our analysis suggests that, at least by day 28 post-infection, the gut is not contributing
greatly to the plasma viral load.
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In the first weeks of human immunodeficiency virus (HIV)
infection in humans and simian immunodeficiency virus
(SIV) infection in rhesus macaques, the loss of CD4+ T
lymphocytes in peripheral blood is moderate and transient.
In contrast, there is a rapid and nearly complete depletion
of intestinal CD4+ T cells within first weeks of infection
both in SIV-infected macaques [1-4] and HIV-infected
humans [5], which persists during the course of disease.
This has been attributed to the very high frequency of the
main targets for HIV infection (CD4+ T cells expressing
the CCR5 co-receptor) in gut mucosa [6]. It is also often
proposed that the gastrointestinal tract is the largest
lymphoid organ in the body, containing more than half of
the total body T-cells [7,8]. In addition, a high proportion
of cells in the lamina propria are CCR5+, and thus highly
susceptible to infection. This has led to a widely accepted
conclusion that the infection of gut CD4+ T cells is the* Correspondence: m.davenport@unsw.edu.au
1Complex Systems in Biology Group, Centre for Vascular Research, University
of New South Wales, Kensington, NSW 2052, Australia
Full list of author information is available at the end of the article
© 2013 Petravic et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the ororigin of the initial burst of viremia, generating the peak
viral load in plasma, and a major contributor to viral
production during infection [1,4,9]. Both ideas have
recently been disputed. The belief that the largest propor-
tion of CD4+ T cells in the body resides in the gut has
been challenged by studies of the post-mortem lympho-
cyte numbers in mammalian organs [10]. We have shown
that it is also improbable that the gut is the main source
of the virus at the peak of viremia, since it is already heavily
depleted of CD4+ T cells days before the peak [11], so
that the observed dynamics of CD4+ T cell depletion is
more consistent with the gut being a smaller compartment
comprising CD4+ T cells that are highly susceptible to
infection [11].
In a recent study of SIVmac239-infected rhesus macaques,
Vanderford et al. [12] followed the appearance of viral
escape mutants (EM) in plasma, lymph nodes (LN), rectal
biopsy (RB) and peripheral blood mononuclear cells
(PBMC), and found evidence that immune pressure in
lymph nodes was the most effective in selecting SIV
escape variants that later dominated the infection in all
tissues. Here we use the data on the content of wild-typel Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tissues from this study to estimate the maximal contribu-
tion of the gut to the plasma viral load during early
infection.
Results and discussion
We used a modeling approach to estimate the maximal
contribution of the gut to plasma viral load. By comparing
fractions of WT in plasma and in tissue-infected cells (LN,
RB and PBMC) 28 days post infection (approximately
2 weeks post peak), we were able to estimate the largest
possible contribution of the virus generated by the infected
cells in the gut to plasma viral load. In its simplest form, if
the viral DNA in gut is 100% WT, but the virus in plasma
is only 10% WT virus, then the gut can contribute at most
10% of the plasma virus. Most samples had between 100
and 9000 sequences, but some (4 LN samples and one
RB sample) had only 1–12 sequences. For the multiple
comparison test we only used the data on the samples
with >100 sequences, so that for this test we only used
the data belonging to10 animals. We found that the
fraction of WT virus in rectal biopsies and in blood was
significantly higher than in plasma, while the difference
in WT content between plasma and lymph nodes was
not significant (Figure 1; p = 0.0018, Friedman test with
Dunn’s multiple comparison post-test).
We estimate the highest possible contribution of the
gut to the plasma viral load for each sample from the
difference in the WT fraction in plasma and in rectal bi-
opsy for each animal. For this estimate we used the data
from all 14 animals that had more than 100 sequences in
RB samples on day 28. In making this estimate we ignored
the data from other tissues (LN and PBMC) because we
did not know which other anatomical compartments (for
which we have no samples) may be contributing, and how
much. When the fraction of WT is higher in RB than inFigure 1 Viral escape in plasma and tissues. A. Escape in plasma, lymph
confidence intervals of a proportion); B. Viral escape in the gut and blood
virus), but not in lymph nodes (Friedman test with Dunn’s multiple compa
compartments in B are represented by the same symbol.plasma, the gut’s contribution to plasma virus is the
highest possible if all WT virus in plasma comes exclusively
from the gut. In this case, the fraction of plasma viral load
that was produced in the gut would be at most
C max ¼ f PL=f cellsRB ð1Þ
where fPL and f
cells
RB are fractions of WT in plasma and rectal
biopsy respectively. However, for two animals (ROu8 and
RWi8) the WT fraction in RB was very close to, but lower
than in plasma. For these two animals, the highest
possible fraction of virus that could have come from the
gut would be
C max ¼ 1−f PLð Þ= 1−f cellsRB
  ð2Þ
when all other tissues were contributing only WT. The
highest possible gut contribution to plasma viral load for
each animal is shown in Figure 2.
Since this method can only estimate the maximal con-
tribution of gut to plasma viral load, high estimates of this
fraction are not very informative. That is, if gut is 100%
WT and plasma is 100% WT (ie: no escape has occurred),
then we would estimate the maximal contribution is
100%. Similarly, if escape has only proceeded to 50% WT
in plasma, we would estimate the maximal gut contribu-
tion as 50%. In each case, the contribution of the gut
could be any number lower than this (or even zero), and
still be compatible with the data. Therefore, although the
mean maximal possible gut contribution to plasma is 25%
(median 9.8%), the actual contribution must simply be less
than this. Since we observe that 7/14 animals have a
gut contribution of <10% at day 28 (and 4/14 ≤3%), we
suspect that the real contribution is likely substantially
less than 10%.
We also analyzed the maximal contribution of gut to
the plasma viral load at day 14 (the peak of infection). Thisnodes, PBMC and rectal biopsy of one animal (error bars represent
lags behind escape in plasma (ie: retaining a higher proportion of WT
rison post-test). Fractions WT belonging to the same animal in different
Figure 2 The highest possible contribution of gut to viral load. A. On day 28 (white part of the bar), estimated from the difference in WT
content in plasma and rectal biopsy; B. Analysis of the proportion of WT virus at peak viral load also suggests a low contribution of virus from the
gut in the few animals that have escape at this time. The arrows indicate that all estimates are of the maximum contribution of the gut, and the
data are equally compatible with any lower figure.
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has not occurred and both plasma virus and gut DNA
virus is close to 100% WT (Additional file 1: Figure S1).
However, in four animals where escape had occurred in
plasma, we estimated that the maximal contribution of
the gut was < 15% for at least two of these animals,
suggesting again that the real value of the gut contribution
may be very small. This is consistent with our previous
work in which we showed that the gut is largely depleted
by the time of peak infection [11]. We note in addition
that in a few animals the gut showed a brief period of early
escape observed on day 10 (Figure 3B). While the mecha-
nisms of this are unclear, the fact that the gut was observed
to contain a significant proportion of EM virus, while the
plasma remained close to 100% WT virus reinforces the
conclusion that also at this early period the gut is unlikely
to be a major contributor to plasma viral load.Figure 3 Longitudinal data on escape in plasma, lymph nodes and re
escape in plasma from day 14; B. In rectal biopsies escape on average lags
confidence intervals of a proportion.One caveat to our analysis is that in estimating the
contribution of the gut to plasma viral load using Eq.1,
we implicitly assumed that the cells infected with WT
and EM virus produce free virus at the same average rates.
However, WT and infected cells may produce different
levels of plasma virus if, for example, either (i) EM virus
has a significant fitness cost (so more WT virus than EM
virus is produced per infected cell), or (ii) WT viral produc-
tion is suppressed by WT-specific immune responses (so
less WT virus is produced per infected cell). In the case of a
fitness cost of escape, this would only decrease the potential
contribution of the gut. However, in the second case, this
would mean that, for example, if infected cells in gut were
50:50 WT:EM, but WT infected cells produced less virus,
we would see less WT in plasma. In this case Eq.1 would
underestimate the contribution of gut. If the average pro-
duction of WT virions pW is different from the averagectal biopsy up to day 28. A. Escape in the lymph nodes precedes
after plasma after peak viral load on day 28. Error bars represent
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highest possible gut contribution to plasma virus Cmax
from the expression:








The derivation of Eq.3 is presented in the Additional
file 2.
Simulation of infection and escape where WT virus
production is suppressed (see Additional file 3 for the
description of the model and Additional file 4 for modeling
results) shows that, if production of WT is preferentially
suppressed by the immune response, escape in all tissues
should always lag after escape in plasma. In this case it
is in principle possible that loss of WT is the slowest in
the largest compartment, but only if it has much higher
infectivity or slower infected cell death rate of infected
cells than the other tissues. However, even under this
scenario, we expect that escape in plasma should be
faster than in all tissues.
The dynamics of escape in lymph nodes and in rectal
biopsies is shown in Figure 3. On average, higher levels
of escape mutants are seen in LN than plasma from day
14 (Figure 3A), while escape in the gut is on average
slower than plasma (Figure 3B). Escape in lymph nodes
considerably precedes plasma in some animals (Additional
file 4: Figure S6). If escape is occurring due to suppression
of WT virus production by CD8+ T cells, it is not possible
to see escape in one tissue preceding plasma virus escape
and another lagging behind (see Additional file 4: Figure S3
to S5). In addition, no evidence exists for lower virus
production by WT-infected cells in vivo, so we do not
believe that suppression of viral production is the dominant
mechanism of escape.
However, on day 28 the distinction is not this clear,
but the dynamics of escape in the gut lag significantly
behind escape in plasma, while the difference in the WT
level between LN and plasma is not statistically significant,
although there is also a (statistically insignificant) trend of
a lag after plasma. Maximum estimates of the contribution
of LN to plasma on day 28 are higher than for the gut
in 9 out of 10 animals for which we have data available,
although the median is only 27% (compared to the median
maximum contribution of 10% by the gut). This would
suggest that LN do not, by themselves, contribute the
largest part of the virus in plasma on day 28, but that
plasma virus is composed of contributions of different
tissues (not all sampled in this study) of which the contri-
bution of the gut is but a small part.
Conclusions
Although the gastrointestinal tract is often thought of as
a large site of susceptible CD4+ T cells and an importantsite of HIV/SIV infection, this study indicates that it is
at best a minor contributor to plasma viral load in early
infection. Since our method estimates the maximum
contribution of virus produced in RB to plasma virus,
we cannot estimate the actual contribution, which could be
very low. However, if we assume that the general dynamics
of infection in different tissues is similar among all animals,
although the dynamics of escape may be much more vari-
able, then the lower estimates of the maximal contribution
would be more informative of the actual fraction of virus
generated in the gut.
Our study is only able to assess the contribution of the
gut to the plasma virus. It is possible that the gut is a
large overall producer of virus, but that most of the virus
produced in the gut either stays in the gut or is filtered
by other tissues on its way to plasma. In this case gut
could still be the major producer of the total body virus,
but not a major contributor to plasma virus.
Our modeling is based upon an implicit assumption
that virus produced in tissues migrates extremely rapidly
to plasma. If there were a long delay from virus production
in tissues until it reaches plasma, this would affect our ana-
lysis. However, studies of viral kinetics under therapy show
a very rapid drop in viral loads after initiation of therapy,
suggesting that any delays between viral production in
tissues and reaching plasma must be very small [13-15].
In our model, we are treating the compartments as if they
were isolated. However, there may be mixing of infected
cells circulating among compartments. For example, the
similarity between PBMC and gut could be explained by
PBMC contributing a large proportion of cells obtained in
the gut biopsies. Similarly, if a large proportion of PBMC
were recycling from the gut, this could also explain the
apparent similarity between the gut and PBMC. We do
not address these possibilities here, nor are we speculating
if the infected cells present in the gut were originally
infected in the gut or elsewhere.
Our estimate of the contribution of the gut to the
plasma virus is also made independent of any estimate of
the proportion of infected cells that reside in the gut. If
infected cells in the gut produce virus at the same rate as
infected cells elsewhere, then the proportion of infected
cells residing in the gut will be the same as our estimated
contribution of the gut to the plasma viral load. However
if, for example, infected cells in the gut produced less virus
than elsewhere, then the proportion of infected cells in
the gut may be higher than would be expected based on
their contribution to plasma viral load.
One limitation to our study is that only one site in gut
has been sampled – rectal biopsy. Therefore, an important
implicit assumption in this work is that the rectal tissue
sampled is broadly reflective of the gut as a whole. Rectal
biopsies represent only a subset of the entire gastrointes-
tinal tract, and in fact differences have been reported by
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features in different parts of the gastrointestinal tract [16].
However, other work has argued that similar levels of
infection and depletion of CD4+ T cells are seen in the
upper gastrointestinal tract and rectal biopsy [1,2]. This is
a limitation that most studies of SIV/HIV infection of the
gut have suffered from, as they have been limited by
access to tissues, and by necessity have had to extrapolate
from one or a few sites to the entire GALT. Rectal biopsies
have been used in many studies of SIV immunology and
pathogenesis [17-19] and, while perhaps not representative
of the entire gastrointestinal tract immunology in every
respect, we believe they provide robust and reproducible
immunological and virological information in the context
of SIV infection of macaques.
Another limitation of our study is that we can study
the contribution of gut only in the period around the
time of immune escape, when the proportion of WT virus
differs between blood and gut. Our method should be
generally applicable to studying the sources of viral
production in HIV, as long as suitable markers for differ-
ent viral strains can be identified. Further work should
aim to clarify the contribution of gut to plasma virus at
different times in HIV infection.Methods
The experimental protocol and primary data have
been published elsewhere [12]. Briefly, 15 MamuA*01
rhesus macaques (10 previously vaccinated with 2 dif-
ferent vaccines and 5 unvaccinated) were challenged
with SIVmac239. Blood, plasma, lymph nodes and rec-
tal biopsies were collected at multiple times pre- and
post-challenge. Plasma viral loads were determined
using a real-time PCR assay specific for the SIVmac239
genome. 454 deep sequencing was used to identify
and quantify escape mutations in MamuA*01-re-
stricted immunodominant tat-SL8 epitope in multiple
tissues. Escape at tat-SL8 was detected in all samples
from all animals and occurred using a variety of amino
acid substitutions.Ethics statement
These studies were carried out in strict accordance with
the recommendations in the Guide for the Care and Use
of Laboratory Animals of the National Institutes of
Health, and were approved by the Emory University
(AWA# A3180-01) and University of Pennsylvania
(AWA# A3079-01) Institutional Animal Care and Use
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performance of any procedure, and proper steps were
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